BN 50341
Product Specifications
UNSPSC Description
BN 50341 is an orally active anticalcic agent and a benzazepine derivative. BN 50341 decreases the in vivo electrically induced thrombus formation in rat or guinea-pig artery and can be utilized in cardiovascular research[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bn-50341.html
Smiles
COC1=CC(CCN(CCCN2C=CC3=C(C(C2)C4=CC=CC=C4)C=C(OC)C(OC)=C3)C)=CC=C1OC.Cl
Molecular Weight
553.13
References & Citations
[1]Etienne A, et al. Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. Agents Actions Suppl. 1986;20:259-66.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-116400/BN-50341-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-116400/
Clinical Information
No Development Reported
CAS Number
107550-66-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9335137-01 48 Well
Human Serologically defined colon cancer antigen 3, SDCCAG3 ELISA Kit
Ask
View Details MBS9335137-02 96 Well
Human Serologically defined colon cancer antigen 3, SDCCAG3 ELISA Kit
Ask
View Details 
MBS9335137-03 5x 96 Well
Human Serologically defined colon cancer antigen 3, SDCCAG3 ELISA Kit
Ask
View Details MBS9335137-04 10x 96 Well
Human Serologically defined colon cancer antigen 3, SDCCAG3 ELISA Kit
Ask
View Details 